BREMAX BREMAX BREMAX

Dose: 1 mg
Single Dose: 1 (1)
Frequency: 12 hourly
Route: PO
Instructions:

Dose: 0.02 to 0.04 mg/kg
Single Dose: 0.03 (0.03)
Frequency: 12 hourly
Route: Oral
Instructions: Recommended for 6-12 Yrs of Children

belongs to Phenylethanol. It belongs to Beta-2 adrenergic agonist pharmacological group on the basis of mechanism of action and also classified in Bronchodilator pharmacological group.The Molecular Weight of Tulobuterol (HCl) is 264.20.

Tulobuterol (HCl)

The severe or irreversible adverse effects of Tulobuterol (HCl), which give rise to further complications include Hypertension, Angina, CNS stimulation.The symptomatic adverse reactions produced by Tulobuterol (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Vomiting, Palpitation, Insomnia, VertigoX.

Tulobuterol (HCl) is primarily indicated in conditions like Asthma, Bronchospasm, Chronic bronchitis, Emphysema.

No data regarding the interactions of Tulobuterol (HCl) was found.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Use with caution in the patient with diabetes mellitus, hypertension and hyperthyroidism. As with other sympathomimetic bronchodilators agents, tulobuterol should be administered cautiously to cardiac patient, espacially those with associated arrhythmias or coronary insufficiency. The concomitant systemic use of tulobuterol with other combined effect on the cardiovascular system may be deleterious to the patient. Tolubuterol should not be prescribed together with beta-blocking agents. Although an intravenous injection of a cardio-selective beta-blocking agent can be given as an specific antidote for tulobuterol over dosage, the agents should be used with caution in the patients with bronchospasm.